Cargando…
Considerations for bioanalytical characterization and batch release of COVID-19 vaccines
The COVID-19 pandemic has prompted hundreds of laboratories around the world to employ traditional as well as novel technologies to develop vaccines against SARS-CoV-2. The hallmarks of a successful vaccine are safety and efficacy. Analytical evaluation methods, that can ensure the high quality of t...
Autores principales: | Sanyal, Gautam, Särnefält, Anna, Kumar, Arun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044082/ https://www.ncbi.nlm.nih.gov/pubmed/33850138 http://dx.doi.org/10.1038/s41541-021-00317-4 |
Ejemplares similares
-
Independent control of COVID-19 vaccines by EU Official Control Authority Batch Release: challenges, strengths and successes
por: Milne, Catherine, et al.
Publicado: (2023) -
Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies
por: Sanyal, Gautam
Publicado: (2022) -
Safety and Considerations of the COVID-19 Vaccine Massive Deployment
por: Li, Junwei, et al.
Publicado: (2021) -
Availability and use of Standards in vaccine development
por: Avumegah, Michael Selorm, et al.
Publicado: (2023) -
Bioanalytical Assay Strategies and Considerations for Measuring Cellular Kinetics
por: Hays, Amanda, et al.
Publicado: (2022)